Meritage Portfolio Management / VRTX
Meritage Portfolio Management’s Vertex Pharmaceuticals Inc Position
Does Meritage Portfolio Management own Vertex Pharmaceuticals Inc (VRTX)? Yes — 25.4K shares worth $12M (+0.77% of its 13F portfolio) as of Q4 2025, down from 25.9K shares the prior filed quarter.
Position Value
$12M
Q4 2025
Shares
25.4K
% of Portfolio
+0.77%
Quarters Held
14
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 25.4K | $12M | +0.77% |
| Q3 2025 | 25.9K | $10M | +0.68% |
| Q2 2025 | 32.9K | $15M | +0.93% |
| Q1 2025 | 34.9K | $17M | +1.12% |
| Q4 2024 | 35.7K | $14M | +0.89% |
| Q3 2024 | 36.5K | $17M | +1.04% |
| Q2 2024 | 37.1K | $17M | +1.10% |
| Q1 2024 | 37.6K | $16M | +1.00% |
| Q4 2023 | 39.3K | $16M | +1.06% |
| Q3 2023 | 24.3K | $8M | +0.63% |
| Q2 2023 | 24.3K | $9M | +0.61% |
| Q1 2023 | 25.2K | $8M | +0.60% |
| Q4 2022 | 25.8K | $7M | +0.58% |
| Q3 2022 | 27.1K | $8M | +0.65% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meritage Portfolio Management’s full portfolio or all institutional holders of VRTX.